Simren Magnus, Palsson Olafur S, Whitehead William E
Department of Internal Medicine & Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 40530, Gothenburg, Sweden.
Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Curr Gastroenterol Rep. 2017 Apr;19(4):15. doi: 10.1007/s11894-017-0554-0.
The purpose of the review was to provide an update of the Rome IV criteria for colorectal disorders with implications for clinical practice.
The Rome diagnostic criteria are expert consensus criteria for diagnosing functional gastrointestinal disorders (FGIDs). The current version, Rome IV, was released in May of 2016 after Rome III had been in effect for a decade. It is the collective product of committees that included more than 100 leading functional GI experts. For functional bowel and anorectal disorders, the majority of changes relative to Rome III are relatively minor and will have little impact on clinical practice. However, notable changes with potential impact on clinical practice and research include the changes in the diagnostic criteria for IBS, the modified approach for subtyping of IBS, the view on functional bowel disorders as a spectrum of disorders, and the new definition of fecal incontinence. New features in the Rome IV diagnostic criteria for functional bowel and anorectal disorders will likely have modest influence on clinical practice, with a few exceptions.
本综述旨在更新罗马IV标准,该标准用于结直肠疾病且对临床实践具有指导意义。
罗马诊断标准是用于诊断功能性胃肠疾病(FGIDs)的专家共识标准。当前版本罗马IV于2016年5月发布,此时罗马III已经实施了十年。它是由包括100多位顶尖功能性胃肠病专家的委员会共同制定的成果。对于功能性肠病和肛肠疾病,相对于罗马III的大多数变化相对较小,对临床实践影响不大。然而,对临床实践和研究可能产生影响的显著变化包括肠易激综合征(IBS)诊断标准的改变、IBS亚型分类的改良方法、将功能性肠病视为一系列疾病的观点以及粪便失禁的新定义。罗马IV功能性肠病和肛肠疾病诊断标准的新特点可能对临床实践影响不大,但有一些例外情况。